[TNXP] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
06-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -21.05%
YoY- 23.65%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -11,990 -7,838 -5,479 -5,786 -7,578 -13,250 -7,419 8.32%
Tax 0 -5 0 -16 0 0 0 -
NP -11,990 -7,838 -5,479 -5,786 -7,578 -13,250 -7,419 8.32%
Tax Rate - - - - - - - -
Total Cost 11,990 7,838 5,479 5,786 7,578 13,250 7,419 8.32%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -603.27 0.00 0.00 0.00 0.00 0.00 0.00 -
EPS Diluted -603.27 0.00 0.00 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.